BCKDK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.856800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.411200E-01
Normal-vs-Stage2
8.774800E-01
Normal-vs-Stage3
4.523400E-01
Normal-vs-Stage4
9.228200E-01
Stage1-vs-Stage2
1.334220E-01
Stage1-vs-Stage3
7.942200E-01
Stage1-vs-Stage4
1.661850E-01
Stage2-vs-Stage3
1.388770E-01
Stage2-vs-Stage4
7.678600E-01
Stage3-vs-Stage4
3.210800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.375200E-01
Normal-vs-AfricanAmerican
9.506800E-01
Normal-vs-Asian
7.016000E-01
Caucasian-vs-AfricanAmerican
8.409200E-01
Caucasian-vs-Asian
3.430400E-01
AfricanAmerican-vs-Asian
6.376200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.599200E-01
Normal-vs-Female
8.934200E-01
Male-vs-Female
2.303200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.345400E-01
Normal-vs-Age(41-60Yrs)
6.793600E-01
Normal-vs-Age(61-80Yrs)
7.832600E-01
Normal-vs-Age(81-100Yrs)
8.542400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.333400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.110600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.351600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.428020E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.285600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.379400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.925400E-01
Normal-vs-Daily Drinker
8.312800E-01
Normal-vs-Weekly Drinker
7.365000E-01
Normal-vs-Occasional Drinker
8.266800E-01
Normal-vs-Social Drinker
9.160400E-01
Non Drinker-vs-Daily Drinker
1.911210E-01
Non Drinker-vs-Weekly Drinker
1.540040E-01
Non Drinker-vs-Occasional Drinker
2.019200E-01
Non Drinker-vs-Social Drinker
3.540000E-01
Daily Drinker-vs-Weekly Drinker
7.654400E-01
Daily Drinker-vs-Occasional Drinker
9.162800E-01
Daily Drinker-vs-Social Drinker
8.852000E-01
Weekly Drinker-vs-Occasional Drinker
6.737400E-01
Weekly Drinker-vs-Social Drinker
7.130400E-01
Occasional Drinker-vs-Social Drinker
9.479400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.092400E-01
Normal-vs-Grade 2
9.667000E-01
Normal-vs-Grade 3
9.916600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.297360E-03
Grade 1-vs-Grade 3
7.403400E-04
Grade 1-vs-Grade 4
8.092400E-01
Grade 2-vs-Grade 3
3.367000E-01
Grade 2-vs-Grade 4
9.667000E-01
Grade 3-vs-Grade 4
9.916600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.909200E-01
Normal-vs-NonDiabetic
9.139400E-01
Diabetic-vs-NonDiabetic
7.652400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.488350E-01
Normal-vs-NoPancreatitis
8.896200E-01
Pancreatitis-vs-NoPancreatitis
5.785400E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.611200E-01
Normal-vs-N1
9.033600E-01
N0-vs-N1
1.539360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.252800E-01
Normal-vs-TP53-NonMutant
1.501360E-01
TP53-Mutant-vs-TP53-NonMutant
3.841600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
